Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
FERNANDO ANTONIO
RODRÍGUEZ DE FONSECA
Catedrático de universidad
Publicaciones en las que colabora con FERNANDO ANTONIO RODRÍGUEZ DE FONSECA (26)
2022
-
2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease
Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272
-
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"
Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461
2020
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
2019
-
Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
Scientific Reports, Vol. 9, Núm. 1
2017
-
Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration
Addiction Biology, Vol. 22, Núm. 3, pp. 724-741
2016
2015
-
Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats
International Journal of Neuropsychopharmacology, Vol. 18, Núm. 6, pp. 1-14
2014
-
Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results
Drug Design, Development and Therapy, Vol. 8, pp. 263-277
2013
-
Description of a bivalent cannabinoid ligand with hypophagic properties
Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179
-
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1708-1716
1996
-
Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats
Behavioural Brain Research, Vol. 75, Núm. 1-2, pp. 91-98
1994
-
Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement
Life Sciences, Vol. 54, Núm. 3, pp. 159-170
-
Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment
Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 33-40
-
Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids
Pharmacology, Biochemistry and Behavior, Vol. 47, Núm. 1, pp. 47-58
1993
-
Acute effects of ∆<sup>9</sup>-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle
Neuroendocrinology, Vol. 58, Núm. 3, pp. 280-286
-
Presence of cannabinoid binding sites in the brain from early postnatal ages
NeuroReport, Vol. 4, Núm. 2, pp. 135-138
-
δ9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens
Journal of Neural Transmission, Vol. 92, Núm. 2-3, pp. 81-95
1992
-
Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas
Pharmacology, Biochemistry and Behavior, Vol. 42, Núm. 2, pp. 269-275
-
Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids
Pharmacology, Biochemistry and Behavior, Vol. 41, Núm. 3, pp. 469-474
-
Estrogenic modulation of δ9-Tetrahydrocannabinol effects on nigrostriatal dopaminergic activity in the female rat brain
Molecular and Cellular Neuroscience, Vol. 3, Núm. 4, pp. 315-325